Drug Profile
Davalintide
Alternative Names: AC 2307; Second generation amylinomimeticLatest Information Update: 28 Dec 2012
Price :
$50
*
At a glance
- Originator Amylin Pharmaceuticals
- Class Multiprotein complexes; Obesity therapies; Peptides; Proteins
- Mechanism of Action Amylin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity; Psychiatric disorders